Register Now
Why register?
Login
 The leading web portal for pharmacy resources, news, education and careers August 18, 2017
Pharmacy Choice - Pharmaceutical News - Plant Advanced Technologies: Anti-Inflammatory Active Compound Presented At BIO Convention in San Diego - August 18, 2017

Pharmacy News Article

 6/19/17 - Plant Advanced Technologies: Anti-Inflammatory Active Compound Presented At BIO Convention in San Diego

VAND?UVRE-L?S-NANCY, France(BUSINESS WIRE) Regulatory News:

Plant Advanced Technologies (Paris:ALPAT):

PAT1657 (patent pending), an innovative active pharmaceutical ingredient (API), proved its potential to treat skin inflammation pathologies. This product developed at preclinical stage is now ready for licensing to pharmaceutical groups, as set out during IPO on Euronext GrowthTM (formerly Alternext) in 2015.

This drug candidate for the treatment of skin inflammations is presented for the first time at BIO International Convention in San Diego, June 19-22. This important event gathers pharmaceutical and biotech companies exhibiting the latest innovations in life science. Frdric Bourgaud, PhD, head of PAT research, and Jean-Franois Ginglinger, PhD pharmaceutical products development manager, will be representing PAT during this global event.

PAT1657 is obtained from PAT plant milking technology and is optimized by hemi-synthesis. Results for this API show strong efficacy for chronic inflammation and psoriasis on mice models, without side effects compared to the market reference in corticosteroids.

PAT1657 is expected to trigger interest from pharmaceutical companies looking for innovative drugs. This global event should allow the Group to accelerate its commercialization.

All about PAT at www.plantadvanced.com
More about BIO 2017: http://convention.bio.org/

About Plant Advanced Technologies PAT:
PAT is a plant biotechnology company producing rare, new actives of plant origin designed for pharmaceutical, cosmetic and agrochemical markets.
PAT exclusive know-how is worldwide patented (PAT plant milking et Target Binding).
PAT is listed on Euronext GrowthTM of Euronext Paris (ISIN code: FR0010785790 Mnemonic code: ALPAT).

Plant Advanced Technologies

Relations investisseurs

Jean-Paul FEVRE, Tl. : +33 (0)3 83 94 03 42

contact@plantadvanced.com

or

Aelium

Communication financire

Solne KENNIS /Jrme GACOIN, Tl. : +33 (0)1 75 77 54 68

skennis@aelium.fr

Source: Plant Advanced Technologies



Copyright Business Wire 2017

Pharmacy News Index
  Drug Delivery Systems
  Drugstores
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry

LIVE ONLINE CE

Aug 21: An Integrative Approach to Managing Arthritis
Aug 22: Men's Health
Aug 23: Biosimilar Drugs: Legal, Regulatory & Safety Considerations
Aug 24: Treatment of Parkinson's Disease and Comorbid Conditions
Aug 25: NSAIDs, Acetaminophen and Adjuvants in Pain Management
Click for entire Webinar Calendar

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Nursing Jobs
Are you a nurse looking for a job?

Check out the Nursing Job Source.

Your number one choice for nursing jobs.



Websites » RxCareerCenter.comRxSchool.comClubStaffing.comNursingJobSource.comRN.com
Copyright © 2017 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement
888-682-4415